Tricida
Latest round
- Series D
Last raised
- Nov 2017
Total raised
- $109M
Investors
- 8
About Tricida
Tricida, Inc.Tricida, Inc. specializes in biopharmaceuticals aimed at treating kidney disorders.00 mn, supported by Hercules Capital.00 mn.Tricida focuses on developing therapies for kidney-related disorders, specifically targeting metabolic acidosis in patients with chronic kidney disease (CKD) on sodium-restricted diets. Their lead therapeutic candidate aims to restore acid-base balance, meeting critical medical needs in the CKD patient population.Tricida's revenue model is centered around the commercialization of their lead therapeutic through direct sales to healthcare providers and partnerships with pharmaceutical distributors. They engage in supply agreements with hospitals and clinics to ensure accessibility of their treatment, reflecting a B2B model that collaborates with healthcare professionals to address patient needs in kidney disease management.30 mn by selling shares on the NASDAQ, the company is looking to expand their market presence. They aim to enter new geographic regions and explore further partnerships to enhance access to their therapies, thereby reinforcing their commitment to addressing unmet medical needs in the kidney disease sector.
Who invested in Tricida
8 investors across 4 rounds
See all investors in Tricida
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tricida
Who invested in Tricida?
Tricida has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tricida raised?
Tricida has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Tricida last raise money?
Tricida's most recent round on record is a Series D, in Nov 2017.
What does Tricida do?
Tricida is a pharmaceuticals company.
Where is Tricida headquartered?
Tricida is headquartered in San Francisco, US.
Which VCs invest in companies like Tricida?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Tricida's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Tricida? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.